Fully agree with you Slammer markets are shockers at valuing bio-stocks. A while ago investors stumped up 10M dollars at 90 cents. How wrong were they. ouchhhhh and some paid out 1.80!!!!!!!! WTH. Only good data will lift this slump not waxing lyrical about funding. Since the funding arrangements the share price has only gone down on the news of 3.8M dollars in CR costing them 4.56M in convertible notes. Shocking deal which the market is punishing with their selling.
Market valuation., page-7
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
